Not Yet Recruiting
A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney Transplant
NCT07613359
- Conditions
- Antibody-Mediated Rejection (AMR)
- Locations
-
Not specified